TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial.
Clinical trial NCT02980029 · TERMINATED
Trial details
- NCT number
- NCT02980029
- Sponsor
- Mark Evers
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-06
- Primary completion
- 2023-10-22
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.